The decision – first reported by Stat citing Biogen’s head of corporate development, Adam Keeney – is not an exit from the digital health category, but an acknowledgement that Biogen will ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Biogen (BIIB – Research Report), with a price target ...